Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.
Anatomy and Embryology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
Genes (Basel). 2021 Apr 22;12(5):629. doi: 10.3390/genes12050629.
The present study was conducted to investigate the effects of colloidal nanoparticles of silver (Nano-Ag) on the expression of myogenesis-related genes in chicken embryos. The investigated genes included the members of the myogenic regulatory factors family () and myocyte enhancer factor 2A () genes. A total of 200 fertilized broiler eggs (Indian River) were randomly distributed into four groups; non-injected control, injected control with placebo, treatment I in ovo injected with 20 ppm Nano-Ag, and treatment II in ovo injected with 40 ppm Nano-Ag. The eggs were then incubated for 21 days at the optimum temperature and humidity conditions. Breast muscle tissues were collected at the 5th, 8th, and 18th days of the incubation period. The mRNA expression of myogenic determination factor 1 (), myogenic factor 5 (), myogenic factor 6 (), myogenin (), and was measured at the three sampling points using real-time quantitative PCR, while MYOD1 protein expression was evaluated on day 18 using western blot. Breast muscle tissues were histologically examined on day 18 to detect the changes at the cellular level. Our results indicate that myogenesis was enhanced with the low concentration (20 ppm) of Nano-Ag due to the higher expression of , , and at the transcriptional level and at the translational level. Moreover, histological analysis revealed the presence of hyperplasia (31.4% more muscle fibers) in treatment I (injected with 20 ppm). Our findings indicate that in ovo injection of 20 ppm Nano-Ag enhances the development of muscles in chicken embryos compared with the 40-ppm dosage and provide crucial information for the use of silver nanoparticles in poultry production.
本研究旨在探讨胶体纳米银(Nano-Ag)对鸡胚中与肌生成相关基因表达的影响。所研究的基因包括肌生成调节因子家族的成员(MyoD、Myf5、Myf6、Myogenin 和 Mrf4)和肌细胞增强因子 2A(MEF2A)基因。总共 200 枚受精的肉鸡(印度河)被随机分为四组:非注射对照组、注射安慰剂对照组、胚胎内注射 20ppm Nano-Ag 处理 I 组和胚胎内注射 40ppm Nano-Ag 处理 II 组。然后,将这些鸡蛋在最佳温度和湿度条件下孵化 21 天。在孵化期的第 5、8 和 18 天采集胸肌组织。在三个采样点使用实时定量 PCR 测量肌生成决定因子 1(MyoD1)、肌生成因子 5(Myf5)、肌生成因子 6(Myf6)、肌生成素(Myogenin)和 MEF2A 的 mRNA 表达,而在第 18 天使用 Western blot 评估 MYOD1 蛋白表达。在第 18 天对胸肌组织进行组织学检查,以检测细胞水平的变化。我们的结果表明,由于低浓度(20ppm)Nano-Ag 导致转录水平的 、 、 和 以及翻译水平的 表达增加,肌生成增强。此外,组织学分析显示处理 I(注射 20ppm)存在增生(肌肉纤维增加 31.4%)。我们的研究结果表明,与 40ppm 剂量相比,胚胎内注射 20ppm Nano-Ag 可增强鸡胚肌肉的发育,并为纳米银在禽类生产中的应用提供了重要信息。